electroCore to Announce Second Quarter 2019 Financial Results on Tuesday, August 13

BASKING RIDGE, N.J., Aug. 06, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. ECOR, a commercial-stage bioelectronic medicine company, announced that it will report financial results for the second quarter and six-months ended June 30, 2019 after the close of the market on Tuesday August 13, 2019.  Management will host a conference call and webcast at 4:30pm Eastern Time to discuss the financial results and answer questions.

About electroCore, Inc.
electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology and rheumatology. The company's current indications are for the preventative treatment of cluster headache and acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.

Investors:
Hans Vitzthum
LifeSci Advisors
(+1) 617-535-7743
hans@lifesciadvisors.com

or

Media Contact:
Sara Zelkovic
LifeSci Public Relations
(+1) 646-876-4933
sara@lifescipublicrelations.com